Argo Biopharma Reports Positive Phase II Data for BW-20805 in HAE
Shanghai, China and New York, USA, September 4, 2026 Argo Biopharma has announced updated Phase II clinical results for...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Shanghai, China and New York, USA, September 4, 2026 Argo Biopharma has announced updated Phase II clinical results for...
Silver Spring, Maryland, USA, September 3, 2026 The U.S. Food and Drug Administration (FDA) has issued a Request for...
North Chicago, Illinois, USA, September 3, 2026 AbbVie has completed its acquisition of Apogee Therapeutics, strengthening the pharmaceutical company’s...
Alameda, California, USA, September 4, 2026 Acepodia has announced that the U.S. Food and Drug Administration (FDA) has cleared...
Audubon, Pennsylvania, USA, September 3, 2026 Globus Medical has announced that its Excelsius3Dâ„¢ Imaging System has received the CE...
